Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
TCR2 Therapeutics
Biotech
TCR2 taps ElevateBio to manufacture T-cell therapy for phase 2
TCR2's endgame was always to manufacture its T-cell therapies in-house. But, in the meantime, it's getting a little help from a Boston-area neighbor.
Amirah Al Idrus
Nov 10, 2020 8:00am
TCR2's T-cell therapy curbs solid tumors in early phase 1 data
Jul 27, 2020 10:45am
TCR2 IPO hits midpoint, setting stage for trials of CAR-T rivals
Feb 15, 2019 10:15am
Immuno-oncology player TCR2 Therapeutics tees up for $80M IPO
Feb 4, 2019 10:52am
Athenex rakes in $100M, sets up Chinese TCR-focused JV
Jul 2, 2018 11:35am
Chutes & Ladders—Ex-Ariad CEO leads Roivant and Arbutus’ RNA JV
Apr 13, 2018 7:52am